谷歌Chrome浏览器插件
订阅小程序
在清言上使用

Maternal siRNA silencing of placental SAA2 mitigates preterm birth following intrauterine inflammation

FRONTIERS IN IMMUNOLOGY(2022)

引用 0|浏览9
暂无评分
摘要
The placental inflammatory processes induced maternally result in preterm birth (PTB). Serum amyloid A (SAA) is a well-known biomarker of inflammation. The objective of this study was to investigate whether murine placental SAA isoforms (SAA1-4) participate in the mechanism of spontaneous PTB and whether maternal regulation of SAA production may serve as a therapeutic approach. During the gestation, all isoforms of SAA were detectable except SAA2. The mouse model of intrauterine inflammation was established using LPS infusion to the uterus. Following intrauterine inflammation, placental SAA2 increased significantly. Inhibition of Saa2, using siSaa2, markedly decreased PTB. The increased placental expression of pro-inflammatory cytokines Il1 beta, Il6, and Tnf alpha were downregulated by siSaa2 treatment. Maternal inhibition of Saa2 did not change the expression of Saa1-4 in the fetal brain. Explant inflammatory culture of placentas with siSaa2 showed similar results to our in vivo experiments. This study demonstrates the highly expressed placental SAA2 as a novel therapeutic target, and maternal administration of siRNA as a promising approach to alleviate PTB.
更多
查看译文
关键词
preterm birth,intrauterine inflammation,serum amyloid A (SAA),placenta,siRNA treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要